AGXT and primary hyperoxaluria type 1: A number of data show that the final outcome of PH1 benefits much from presymptomatic screening and timely accurate diagnosis which mainly depends on AGXT mutation screening, liver biopsy, or elevated plasma and urine oxalate level and so on.